AI-powered blood test detects Parkinson's disease years before symptoms appear, revolutionizing early diagnosis and treatment ...
London, has collaborated with the London-based advocacy group Parkinson's In Motion and The Michael J. Fox Foundation (MJFF) ...
The FDA approved a monthly maintenance dosing of intravenous lecanemab (Leqembi) for early Alzheimer's disease, said ...
A few years after Patrick Morrissey, 53, learned he had early onset Parkinson's disease, a group of friends came to him with ...
Inhibikase Therapeutics announced disappointing results from a Phase 2 trial for its Parkinson’s disease drug, risvodetinib, and will now pause its development.
A Colorado Springs family hopes to win what they believe would be a landmark legal verdict by proving to jurors next month ...
A new EPA ban on TCE, a common industrial cleaning agent and contaminant, begins this year. UCSF’s Samuel Goldman, who led groundbreaking research to link TCE to Parkinson’s Disease, talks about the ...
Patients living with Parkinson’s disease are encouraged to engage in regular exercise to help manage symptoms and improve ...
At Rock Steady Boxing West Michigan, patients are using boxing as a form of therapy to combat the effects of Parkinson's.
WEST BEND, Wis. — Rock Steady Boxing participants live with a form of Parkinson's disease and want to raise awareness and ...
Inhibikase Therapeutics said on Wednesday it would stop development of its experimental Parkinson's disease drug after it failed to improve patients' ability to carry out daily tasks such as eating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback